1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ceca1 protein, drosophila in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ceca1 protein, drosophila) | Trials (ceca1 protein, drosophila) | Recent Studies (post-2010) (ceca1 protein, drosophila) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 270 | 0 | 88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baglioni, C; Bussolino, F; Camussi, G; Turello, E | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ceca1 protein, drosophila
| Article | Year |
|---|---|
Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells.
Topics: Amino Acid Sequence; Anti-Inflammatory Agents, Non-Steroidal; Antimicrobial Cationic Peptides; Cell Membrane Permeability; Cytoskeletal Proteins; Endothelium, Vascular; Fluorescent Antibody Technique; Humans; Insect Hormones; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Platelet Activating Factor; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1991 |